December 03, 2024FinancialNotice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
December 03, 2024CorporateMulti-Center Superiority Clinical Trial, Supported by Terumo Blood and Cell Technologies, Aims to Significantly Reduce Complications From Acute Chest Syndrome in Adult Sickle Cell Disease Patients
December 03, 2024CorporateTerumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support CatheterProvides interventionalists with optimal product choices for more complex radial-to-peripheral procedures
2022 All pages, single page (PDF 13.04 MB) All pages, 2 pages spread (PDF 12.89 MB) Please refer to the ESG Section here.2021 All pages, single page (PDF 22.85 MB) All pages, 2 pages spread (PDF 22.77 MB) 2020 Japanese (PDF 3.47 MB) English (PDF 3 MB) Financial Information (English) (PDF 1.48 MB) 2019 Japanese (PDF 3.36 MB) English (PDF 2.92 MB) Financial Information (English) (PDF 1.5 MB) 2018 Japanese (PDF 2.23 MB) English (PDF 1.97 MB) Financial Information (English) (PDF 1.72 MB) 2017 Japanese (PDF 7.59 MB) English (PDF 6.53 MB) Financial Information (English) (PDF 2.93 MB) DisclaimerAdobe Reader is required for viewing PDF files.Download Adobe Reader
Top
Top